Search
UCSF Health Cancer Services Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
The UCSF cancer program has been continuously accredited by the CoC since 1933, demonstrating its commitment to the best outcomes possible for its cancer patients.UCSF Oral Oncology
The UCSF Oral Oncology Clinic offers consultations for the diagnosis, treatment and management of oral complications from cancer treatment. The clinic is the first and only one of its kind in Northern California.Neck Knowledge: Diagnostics and Care for Growths in Adults
Dr. Patrick Ha, UCSF’s chief of head and neck surgical oncology, breaks down the neck’s complex anatomy and provides a case-based discussion of common growths – including developmental cysts, salivary gland disorders, thyroid masses and HPV-related cancers. Included is a useful diagnostic flowchart.A Concise Guide to Colorectal Cancer for Primary Care Providers
This presentation on colorectal cancer – the third most common cancer in the U.S. – unpacks the risk factors (including how to assess family history); reviews symptoms, treatments and survival data; and offers guidance on meeting patients’ post-treatment needs.Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference...California Center for Pituitary Disorders
The California Center for Pituitary Disorders is the largest practice for pituitary disorders in the United States & performs more pituitary surgeries than any other medical center in the U.S.Multiple Myeloma: Cutting-Edge Induction and Maintenance Therapies Lead to Improved Response Rates and Survival for Newly Diagnosed Patients
Take a deep dive into therapy options for newly diagnosed myeloma patients: whether three drugs are better than two, the case for lenalidomide maintenance therapy, the many improvements in induction treatment, the future of immunotherapy, and more.How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes
Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.CBC: Optimizing Use of an Everyday Blood Test
Hematologist Neil Dunavin, MD, a specialist in blood cancers and BMT, elucidates the commonly ordered yet imperfectly understood complete blood count, with guidance on which differential type to order and which results call for investigation.Advances in Treating Colorectal Cancer With Liver Metastases
Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.Oral Dysplasia Program
Oral dysplasia patients at UCSF benefit from an internationally recognized team of multidisciplinary experts with the highest level of expertise in this difficult-to-manage and often unpredictable disease.Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.Novel Hyperglycemia Management Protocol for Patients Undergoing Cancer Treatment
An innovative hyperglycemia management protocol for patients receiving cancer therapy is provided through an urgent-care site within the UCSF Infusion Center, and can be replicated at other centers. The protocol ensures that patients promptly get the necessary treatment for acute hyperglycemia that can occur during cancer therapy.Screening and Removal of Precancerous Lesions Prevents Anal Cancer
National study led by UCSF is first to show effectiveness of simple strategies to reduce risk of often silent cancer.UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.UCSF Researchers Help Gain FDA Approval for Prostate Cancer Imaging Technique
Method is a ‘game changer’ that should become the standard of care, say UCSF researchers who validated its effectiveness.UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
In a study published December 8, 2022 in Science, UCSF researchers Kevin Lou, an MD-PhD student, Luke Gilbert, PhD, and Kevan Shokat, PhD, reveal the discovery of a cellular uptake pathway important for larger molecules.“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells
New approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up
Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.Hematology and Blood and Marrow Transplant
Specialized treatments for acute and chronic blood conditions, from cancers to the full range of non-malignant blood disordersPhysician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).How AI Found the Words to Kill Cancer Cells
Predictive model allows researchers to encode commands for cells to carry out.New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions
These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers.Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.